ISOLATED RECOMBINANT VIRUS BASED ON INFLUENZA VIRUS FOR INDUCING SPECIFIC IMMUNITY TO INFLUENZA VIRUS AND/OR PREVENTING DISEASES CAUSED BY INFLUENZA VIRUS Russian patent published in 2024 - IPC C12N15/50 C12N15/117 C07K14/165 A61K39/215 A61P31/14 A61P31/16 A61P37/04 

FIELD: biotechnology.

SUBSTANCE: following is described: a group of inventions including an isolated nucleic acid encoding a recombinant polypeptide to increase the titer of antibodies to the influenza virus, including fragments from coronavirus proteins (variants), an isolated recombinant virus based on the influenza virus to induce specific immunity to the influenza virus and coronavirus and/or disease prevention caused by the influenza virus and coronavirus, a pharmaceutical composition, a vaccine, the use of a recombinant virus based on the influenza virus, a pharmaceutical composition or vaccine for inducing specific immunity to the influenza virus and coronavirus and/or preventing diseases caused by the influenza virus and coronavirus, and a method of inducing specific immunity to the influenza virus and coronavirus and/or prevention of diseases caused by the influenza virus and coronavirus.

EFFECT: invention expands the range of agents for inducing specific immunity to the influenza virus and coronavirus and/or preventing diseases caused by the influenza virus and coronavirus.

38 cl, 19 dwg, 9 tbl, 5 ex